In recent preliminary reports published on the internet, Baxter Healthcare Corporation applied for a patent for the vaccine that would immunize the H1N1 Swine Flu.
In August 2007, Baxter Healthcare Corporation, the company developing the swine flu vaccination,
applied for a patent on
many vaccines including H1N1 Swine Flu.
After the application was leaked on the World Wide Web by a United Kingdom publication, justoneclickgroup, it showed that the company also applied for patents to other diseases:
“In particular preferred embodiments the composition orvaccine comprises more than one antigen…..such as influenza A and influenza B in particular selected from of one or more of the human H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, H10N7 subtypes, of the pig flu H1N1, H1N2, H3N1 and H3N2 subtypes, of the dog or horse flu H7N7, H3N8 subtypes or of the avian H5N1, H7N2, H1N7, H7N3, H13N6, H5N9, H11N6, H3N8, H9N2, H5N2, H4N8, H10N7, H2N2, H8N4, H14N5, H6N5, H12N5 subtypes.”
Head of Virology at Baxter’s Austrian subsidiary Otfried Kistner was part of the Austrian-based team that applied for the patent for the H1N1 Swine Flu on August 28, 2007.
Many countries are ordering vaccinations for the recently declared pandemic. Some countries are even making it
mandatory now. However, since the
fifty countries have ordered the vaccines, Baxter has declared that it cannot accept any more requests. Baxter Spokesman Chris Bona said, "At this time we're not in a position to take additional orders."
